APO Research

APO RESEARCH · REPORT

Intracardiac Drug Coated Balloons

Selected research

Market Structure

Global Intracardiac Drug Coated Balloons Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Intracardiac Drug Coated Balloons market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Intracardiac Drug Coated Balloons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intracardiac Drug Coated Balloons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intracardiac Drug Coated Balloons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intracardiac Drug Coated Balloons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intracardiac Drug Coated Balloons include Yinyi Biotech, Yingsheng Medical, Shenqi Medical, Lepu Medical, DK Medical Technology, Cardionovum, Barty Medical and B. Braun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intracardiac Drug Coated Balloons market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intracardiac Drug Coated Balloons and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intracardiac Drug Coated Balloons sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intracardiac Drug Coated Balloons market size, projected growth trends, production technologies, key applications, and end-use industries.

Intracardiac Drug Coated Balloons Segment by Company

Yinyi Biotech

Yingsheng Medical

Shenqi Medical

Lepu Medical

DK Medical Technology

Cardionovum

Barty Medical

B. Braun

Intracardiac Drug Coated Balloons Segment by Type

Spray Coating

Dip Coating

Others

Intracardiac Drug Coated Balloons Segment by Application

In Stent Restenosis (ISR)

Coronary Bifurcation Lesion (CBL)

Others

Intracardiac Drug Coated Balloons Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intracardiac Drug Coated Balloons market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intracardiac Drug Coated Balloons and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intracardiac Drug Coated Balloons.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intracardiac Drug Coated Balloons market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intracardiac Drug Coated Balloons manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intracardiac Drug Coated Balloons in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intracardiac Drug Coated Balloons in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Intracardiac Drug Coated Balloons Industry Trends Table 2. Intracardiac Drug Coated Balloons Industry Drivers Table 3. Intracardiac Drug Coated Balloons Industry Opportunities and Challenges Table 4. Intracardiac Drug Coated Balloons Industry Restraints Table 5. Global Intracardiac Drug Coated Balloons Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Intracardiac Drug Coated Balloons Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Intracardiac Drug Coated Balloons Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Intracardiac Drug Coated Balloons Sales Market Share by Manufacturers Table 9. Global Intracardiac Drug Coated Balloons Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Intracardiac Drug Coated Balloons Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Intracardiac Drug Coated Balloons Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Intracardiac Drug Coated Balloons Manufacturers, Product Type & Application Table 13. Global Intracardiac Drug Coated Balloons Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Intracardiac Drug Coated Balloons by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Spray Coating Table 17. Major Manufacturers of Dip Coating Table 18. Major Manufacturers of Others Table 19. Global Intracardiac Drug Coated Balloons Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Intracardiac Drug Coated Balloons Sales by Type (2021-2026) & (k units) Table 21. Global Intracardiac Drug Coated Balloons Sales by Type (2027-2032) & (k units) Table 22. Global Intracardiac Drug Coated Balloons Sales Market Share by Type (2021-2026) Table 23. Global Intracardiac Drug Coated Balloons Sales Market Share by Type (2027-2032) Table 24. Global Intracardiac Drug Coated Balloons Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Intracardiac Drug Coated Balloons Revenue by Type (2021-2026) & (k units) Table 26. Global Intracardiac Drug Coated Balloons Revenue by Type (2027-2032) & (k units) Table 27. Global Intracardiac Drug Coated Balloons Revenue Market Share by Type (2021-2026) Table 28. Global Intracardiac Drug Coated Balloons Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of In Stent Restenosis (ISR) Table 30. Major Manufacturers of Coronary Bifurcation Lesion (CBL) Table 31. Major Manufacturers of Others Table 32. Global Intracardiac Drug Coated Balloons Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Intracardiac Drug Coated Balloons Sales by Application (2021-2026) & (k units) Table 34. Global Intracardiac Drug Coated Balloons Sales by Application (2027-2032) & (k units) Table 35. Global Intracardiac Drug Coated Balloons Sales Market Share by Application (2021-2026) Table 36. Global Intracardiac Drug Coated Balloons Sales Market Share by Application (2027-2032) Table 37. Global Intracardiac Drug Coated Balloons Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Intracardiac Drug Coated Balloons Revenue by Application (2021-2026) & (k units) Table 39. Global Intracardiac Drug Coated Balloons Revenue by Application (2027-2032) & (k units) Table 40. Global Intracardiac Drug Coated Balloons Revenue Market Share by Application (2021-2026) Table 41. Global Intracardiac Drug Coated Balloons Revenue Market Share by Application (2027-2032) Table 42. Global Intracardiac Drug Coated Balloons Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Intracardiac Drug Coated Balloons Sales by Region (2021-2026) & (k units) Table 44. Global Intracardiac Drug Coated Balloons Sales Market Share by Region (2021-2026) Table 45. Global Intracardiac Drug Coated Balloons Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Intracardiac Drug Coated Balloons Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Intracardiac Drug Coated Balloons Sales by Country (2021-2026) & (k units) Table 49. North America Intracardiac Drug Coated Balloons Sales by Country (2027-2032) & (k units) Table 50. Europe Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Intracardiac Drug Coated Balloons Sales by Country (2021-2026) & (k units) Table 52. Europe Intracardiac Drug Coated Balloons Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Intracardiac Drug Coated Balloons Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Intracardiac Drug Coated Balloons Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Intracardiac Drug Coated Balloons Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Intracardiac Drug Coated Balloons Sales by Country (2027-2032) & (k units) Table 59. Global Intracardiac Drug Coated Balloons Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Intracardiac Drug Coated Balloons Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Intracardiac Drug Coated Balloons Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Intracardiac Drug Coated Balloons Revenue Market Share by Region (2021-2026) Table 63. Global Intracardiac Drug Coated Balloons Revenue Market Share by Region (2027-2032) Table 64. Yinyi Biotech Company Information Table 65. Yinyi Biotech Business Overview Table 66. Yinyi Biotech Intracardiac Drug Coated Balloons Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Yinyi Biotech Intracardiac Drug Coated Balloons Product Portfolio Table 68. Yinyi Biotech Recent Development Table 69. Yingsheng Medical Company Information Table 70. Yingsheng Medical Business Overview Table 71. Yingsheng Medical Intracardiac Drug Coated Balloons Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Yingsheng Medical Intracardiac Drug Coated Balloons Product Portfolio Table 73. Yingsheng Medical Recent Development Table 74. Shenqi Medical Company Information Table 75. Shenqi Medical Business Overview Table 76. Shenqi Medical Intracardiac Drug Coated Balloons Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shenqi Medical Intracardiac Drug Coated Balloons Product Portfolio Table 78. Shenqi Medical Recent Development Table 79. Lepu Medical Company Information Table 80. Lepu Medical Business Overview Table 81. Lepu Medical Intracardiac Drug Coated Balloons Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Lepu Medical Intracardiac Drug Coated Balloons Product Portfolio Table 83. Lepu Medical Recent Development Table 84. DK Medical Technology Company Information Table 85. DK Medical Technology Business Overview Table 86. DK Medical Technology Intracardiac Drug Coated Balloons Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. DK Medical Technology Intracardiac Drug Coated Balloons Product Portfolio Table 88. DK Medical Technology Recent Development Table 89. Cardionovum Company Information Table 90. Cardionovum Business Overview Table 91. Cardionovum Intracardiac Drug Coated Balloons Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Cardionovum Intracardiac Drug Coated Balloons Product Portfolio Table 93. Cardionovum Recent Development Table 94. Barty Medical Company Information Table 95. Barty Medical Business Overview Table 96. Barty Medical Intracardiac Drug Coated Balloons Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Barty Medical Intracardiac Drug Coated Balloons Product Portfolio Table 98. Barty Medical Recent Development Table 99. B. Braun Company Information Table 100. B. Braun Business Overview Table 101. B. Braun Intracardiac Drug Coated Balloons Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. B. Braun Intracardiac Drug Coated Balloons Product Portfolio Table 103. B. Braun Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Intracardiac Drug Coated Balloons Distributors List Table 107. Intracardiac Drug Coated Balloons Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Intracardiac Drug Coated Balloons Product Image Figure 2. Global Intracardiac Drug Coated Balloons Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intracardiac Drug Coated Balloons Market Size (2021-2032) & (US$ Million) Figure 4. Global Intracardiac Drug Coated Balloons Sales (2021-2032) & (k units) Figure 5. Global Intracardiac Drug Coated Balloons Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Intracardiac Drug Coated Balloons Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Spray Coating Image Figure 9. Dip Coating Image Figure 10. Others Image Figure 11. Global Intracardiac Drug Coated Balloons Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Intracardiac Drug Coated Balloons Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Intracardiac Drug Coated Balloons Sales Market Share by Type (2021-2032) Figure 14. Global Intracardiac Drug Coated Balloons Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Intracardiac Drug Coated Balloons Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Intracardiac Drug Coated Balloons Revenue Market Share by Type (2021-2032) Figure 17. In Stent Restenosis (ISR) Image Figure 18. Coronary Bifurcation Lesion (CBL) Image Figure 19. Others Image Figure 20. Global Intracardiac Drug Coated Balloons Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Intracardiac Drug Coated Balloons Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Intracardiac Drug Coated Balloons Sales Market Share by Application (2021-2032) Figure 23. Global Intracardiac Drug Coated Balloons Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Intracardiac Drug Coated Balloons Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Intracardiac Drug Coated Balloons Revenue Market Share by Application (2021-2032) Figure 26. North America Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Intracardiac Drug Coated Balloons Sales Market Share by Country (2021-2032) Figure 28. U.S. Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Intracardiac Drug Coated Balloons Sales Market Share by Country (2021-2032) Figure 33. Germany Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Intracardiac Drug Coated Balloons Sales Market Share by Country (2021-2032) Figure 40. China Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Intracardiac Drug Coated Balloons Sales Market Share by Country (2021-2032) Figure 48. Brazil Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Intracardiac Drug Coated Balloons Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Intracardiac Drug Coated Balloons Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Intracardiac Drug Coated Balloons Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Intracardiac Drug Coated Balloons Revenue (2021-2032) & (US$ Million) Figure 59. North America Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Intracardiac Drug Coated Balloons Revenue (2021-2032) & (US$ Million) Figure 61. Europe Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Intracardiac Drug Coated Balloons Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Intracardiac Drug Coated Balloons Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Intracardiac Drug Coated Balloons Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Intracardiac Drug Coated Balloons Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Spray Coating
  • Dip Coating
  • Others
Applications
  • In Stent Restenosis (ISR)
  • Coronary Bifurcation Lesion (CBL)
  • Others
Companies covered
  • Yinyi Biotech
  • Yingsheng Medical
  • Shenqi Medical
  • Lepu Medical
  • DK Medical Technology
  • Cardionovum
  • Barty Medical
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intracardiac Drug Coated Balloons Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intracardiac Drug Coated Balloons Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Intracardiac Drug Coated Balloons Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Intracardiac Drug Coated Balloons Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Intracardiac Drug Coated Balloons Market Dynamics
  1. 2.1 Intracardiac Drug Coated Balloons Industry Trends
  2. 2.2 Intracardiac Drug Coated Balloons Industry Drivers
  3. 2.3 Intracardiac Drug Coated Balloons Industry Opportunities and Challenges
  4. 2.4 Intracardiac Drug Coated Balloons Industry Restraints
3 Intracardiac Drug Coated Balloons Market by Manufacturers
  1. 3.1 Global Intracardiac Drug Coated Balloons Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Intracardiac Drug Coated Balloons Sales by Manufacturers (2021-2026)
  3. 3.3 Global Intracardiac Drug Coated Balloons Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Intracardiac Drug Coated Balloons Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intracardiac Drug Coated Balloons Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Intracardiac Drug Coated Balloons Manufacturers, Product Type & Application
  7. 3.7 Global Intracardiac Drug Coated Balloons Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intracardiac Drug Coated Balloons Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intracardiac Drug Coated Balloons Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intracardiac Drug Coated Balloons Tier 1, Tier 2, and Tier 3
4 Intracardiac Drug Coated Balloons Market by Type
  1. 4.1 Intracardiac Drug Coated Balloons Type Introduction
  2. 4.1.1 Spray Coating
  3. 4.1.2 Dip Coating
  4. 4.1.3 Others
  5. 4.2 Global Intracardiac Drug Coated Balloons Sales by Type
  6. 4.2.1 Global Intracardiac Drug Coated Balloons Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Intracardiac Drug Coated Balloons Sales by Type (2021-2032)
  8. 4.2.3 Global Intracardiac Drug Coated Balloons Sales Market Share by Type (2021-2032)
  9. 4.3 Global Intracardiac Drug Coated Balloons Revenue by Type
  10. 4.3.1 Global Intracardiac Drug Coated Balloons Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Intracardiac Drug Coated Balloons Revenue by Type (2021-2032)
  12. 4.3.3 Global Intracardiac Drug Coated Balloons Revenue Market Share by Type (2021-2032)
5 Intracardiac Drug Coated Balloons Market by Application
  1. 5.1 Intracardiac Drug Coated Balloons Application Introduction
  2. 5.1.1 In Stent Restenosis (ISR)
  3. 5.1.2 Coronary Bifurcation Lesion (CBL)
  4. 5.1.3 Others
  5. 5.2 Global Intracardiac Drug Coated Balloons Sales by Application
  6. 5.2.1 Global Intracardiac Drug Coated Balloons Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intracardiac Drug Coated Balloons Sales by Application (2021-2032)
  8. 5.2.3 Global Intracardiac Drug Coated Balloons Sales Market Share by Application (2021-2032)
  9. 5.3 Global Intracardiac Drug Coated Balloons Revenue by Application
  10. 5.3.1 Global Intracardiac Drug Coated Balloons Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intracardiac Drug Coated Balloons Revenue by Application (2021-2032)
  12. 5.3.3 Global Intracardiac Drug Coated Balloons Revenue Market Share by Application (2021-2032)
6 Global Intracardiac Drug Coated Balloons Sales by Region
  1. 6.1 Global Intracardiac Drug Coated Balloons Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intracardiac Drug Coated Balloons Sales by Region (2021-2032)
  3. 6.2.1 Global Intracardiac Drug Coated Balloons Sales by Region (2021-2026)
  4. 6.2.2 Global Intracardiac Drug Coated Balloons Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Intracardiac Drug Coated Balloons Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Intracardiac Drug Coated Balloons Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Intracardiac Drug Coated Balloons Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Intracardiac Drug Coated Balloons Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Intracardiac Drug Coated Balloons Revenue by Region
  1. 7.1 Global Intracardiac Drug Coated Balloons Revenue by Region
  2. 7.1.1 Global Intracardiac Drug Coated Balloons Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Intracardiac Drug Coated Balloons Revenue by Region (2021-2026)
  4. 7.1.3 Global Intracardiac Drug Coated Balloons Revenue by Region (2027-2032)
  5. 7.1.4 Global Intracardiac Drug Coated Balloons Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Intracardiac Drug Coated Balloons Revenue (2021-2032)
  8. 7.2.2 North America Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Intracardiac Drug Coated Balloons Revenue (2021-2032)
  11. 7.3.2 Europe Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Intracardiac Drug Coated Balloons Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Intracardiac Drug Coated Balloons Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yinyi Biotech
  2. 8.1.1 Yinyi Biotech Company Information
  3. 8.1.2 Yinyi Biotech Business Overview
  4. 8.1.3 Yinyi Biotech Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yinyi Biotech Intracardiac Drug Coated Balloons Product Portfolio
  6. 8.1.5 Yinyi Biotech Recent Developments
  7. 8.2 Yingsheng Medical
  8. 8.2.1 Yingsheng Medical Company Information
  9. 8.2.2 Yingsheng Medical Business Overview
  10. 8.2.3 Yingsheng Medical Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yingsheng Medical Intracardiac Drug Coated Balloons Product Portfolio
  12. 8.2.5 Yingsheng Medical Recent Developments
  13. 8.3 Shenqi Medical
  14. 8.3.1 Shenqi Medical Company Information
  15. 8.3.2 Shenqi Medical Business Overview
  16. 8.3.3 Shenqi Medical Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shenqi Medical Intracardiac Drug Coated Balloons Product Portfolio
  18. 8.3.5 Shenqi Medical Recent Developments
  19. 8.4 Lepu Medical
  20. 8.4.1 Lepu Medical Company Information
  21. 8.4.2 Lepu Medical Business Overview
  22. 8.4.3 Lepu Medical Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lepu Medical Intracardiac Drug Coated Balloons Product Portfolio
  24. 8.4.5 Lepu Medical Recent Developments
  25. 8.5 DK Medical Technology
  26. 8.5.1 DK Medical Technology Company Information
  27. 8.5.2 DK Medical Technology Business Overview
  28. 8.5.3 DK Medical Technology Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DK Medical Technology Intracardiac Drug Coated Balloons Product Portfolio
  30. 8.5.5 DK Medical Technology Recent Developments
  31. 8.6 Cardionovum
  32. 8.6.1 Cardionovum Company Information
  33. 8.6.2 Cardionovum Business Overview
  34. 8.6.3 Cardionovum Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cardionovum Intracardiac Drug Coated Balloons Product Portfolio
  36. 8.6.5 Cardionovum Recent Developments
  37. 8.7 Barty Medical
  38. 8.7.1 Barty Medical Company Information
  39. 8.7.2 Barty Medical Business Overview
  40. 8.7.3 Barty Medical Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Barty Medical Intracardiac Drug Coated Balloons Product Portfolio
  42. 8.7.5 Barty Medical Recent Developments
  43. 8.8 B. Braun
  44. 8.8.1 B. Braun Company Information
  45. 8.8.2 B. Braun Business Overview
  46. 8.8.3 B. Braun Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 B. Braun Intracardiac Drug Coated Balloons Product Portfolio
  48. 8.8.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intracardiac Drug Coated Balloons Value Chain Analysis
  2. 9.1.1 Intracardiac Drug Coated Balloons Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intracardiac Drug Coated Balloons Production Mode & Process
  6. 9.2 Intracardiac Drug Coated Balloons Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intracardiac Drug Coated Balloons Distributors
  9. 9.2.3 Intracardiac Drug Coated Balloons Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research